Additionally, a study indicates that STING activation in low immunogenic tumors can induce high expression of IDO in a type I IFN-dependent manner, promoting tumor growth, a phenomenon not observed in high immunogenic tumors.221 Interestingly, the expression of IDO is a result of type I IFN-mediated pathway reshaping. Here, STING1 is linked to neoplasm.